Serum CA 125 level in normotensive and pre-eclamptic pregnancies in a tertiary care hospital

Authors

  • Sahithya Sivaprasad Department of Obstetrics and Gynecology, SDUAHER, Kolar, Karnataka, India
  • Sheela S. R. Department of Obstetrics and Gynecology, SDUAHER, Kolar, Karnataka, India
  • Shashidhar Kurpad Nagaraj Department of Biochemistry, SDUAHER, Tamaka, Kolar, Karnataka, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20231929

Keywords:

Pre-eclampsia, Pregnancy, CA125, Hypertension

Abstract

Background: Preeclampsia is one main reason for high-risk pregnancy. Among the disorders in hypertension, preeclampsia develops in antenatal period and it is defined by high blood pressure of more than 140/90 mmHg and arteriolar vasoconstriction, both of which lower uteroplacental perfusion and ultimately lead to placental hypoxia. The objectives of this study was (a) to estimate CA125 level in normotensive and pre eclamptic pregnancies; and (b) to predict severity of pre-eclampsia with CA125 levels with cut off value of CA125 level as 23.7 IU/ml.

Methods: This two year cross sectional study was conducted on all antenatal mothers bestween 20 -40 weeks gestational age getting admitted RLJH and research centre Tamaka (January 2021-December 2022), for the period of 2 years who fulfilled inclusion and exclusion criteria. Detailed clinical history along with antenatal examination was done. For each study subject the blood pressure was recorded. Complete blood picture was done and CA125 levels were done of the study subjects.

Results: Mean CA125 among normal subjects was 24.24±13.71 IU/ml and Mean CA125 among pre-eclampsia subjects was 30.61±15.69 IU/ml. There was a statistical significance found between two groups with respect to CA125.

Conclusions: In pre-eclampsia, CA125 was increased more compared to normotensive group. This indicates the importance in estimation of CA125 level in preeclampsia. The same has been determined with significant p value.

References

Bateman BT, Shaw KM, Kuklina EV, Callaghan WM, Seely EW, Hernández-Díaz S. Hypertension in women of reproductive age in the United States: NHANES 1999-2008. PLoS One. 2012;7(4):e36171.

Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183(1):1-22.

WHO. Make every mother and child count, in the world health report 2005. Geneva, Switzerland: WHO; 2005.

Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066-74.

Upadya M, Rao ST. Hypertensive disorders in pregnancy. Indian J Anaesth. 2018;62(9):675-81.

Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. 2019;15(5):275-89.

Sibai BM, el-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol. 1986;155(5):1011-6.

Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237-60.

Scholler N, Urban N. CA125 in ovarian cancer. Biomark Med. 2007;1(4):513-23.

Funston G, Hamilton W, Abel G, Crosbie EJ, Rous B, Walter FM. The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study. PLoS Med. 2020;17(10):e1003295.

Eltabbakh GH, Gupta MK, Belinson JL, Kennedy AW, Webster K, Paraiso MF. Comparison between Centcor CA 125 and CA 125 II assays. Eur J Gynaecol Oncol. 1996;17(6):504-6.

Geya G, Supriya K. Maternal serum cancer antigen 125: A marker of severity of Preeclampsia. J SAFOG. 2019;11(2):100-2.

Osanyin GE, Okunade KS, Ayotunde OA. Association between serum CA125 levels in preeclampsia and its severity among women in Lagos, South-West Nigeria. Hypertens Pregnancy. 2018;37(2):93-7.

Mukherjee B, Das A. Association between serum ca-125 levels and severity of pre-eclampsia: a case-control study conducted in a tertiary care centre, West Bengal. Int J Reprod Contracept Obstet Gynecol. 2020;9:4176-80.

Sane S, Shokouhi S, Golabi P, Rezaeian M, Kazemi Haki B. The Effect of Dexmedetomidine in Combination with Bupivacaine on Sensory and Motor Block Time and Pain Score in Supraclavicular Block. Pain Res Manag. 2021;2021:8858312.

Chung HH, Kim JW, Park NH, Song YS, Kang SB, Lee HP. Use of preoperative serum CA‐125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Acta Obstet Gynecol Scand. 2006;85(12):1501-5.

Downloads

Published

2023-06-28

Issue

Section

Original Research Articles